New AI technology can provide rapid and reliable dementia diagnosis
en-GBde-DEes-ESfr-FR

New AI technology can provide rapid and reliable dementia diagnosis

27/11/2025 Örebro Universitet

New AI technology can provide rapid and reliable dementia diagnosis

Researchers at Örebro University have developed two new AI models that can analyse the brain's electrical activity and accurately distinguish between healthy individuals and patients with dementia, including Alzheimer’s disease.

“Early diagnosis is crucial in order to be able to take proactive measures that slow down the progression of the disease and improve the patient's quality of life,” says Muhammad Hanif, researcher in informatics at Örebro University.

In the study An explainable and efficient deep learning framework for EEG-based diagnosis of Alzheimer's disease and frontotemporal dementia, researchers combined two advanced AI methods – temporal convolutional networks and LSTM networks. The program analyses EEG signals and can determine almost flawlessly whether a person is sick or healthy.

Can distinguish healthy from sick with 80 per cent certainty

When comparing three groups – Alzheimer's, frontotemporal dementia and healthy – the method achieved over 80 per cent accuracy. The researchers also use an explanatory AI technique that shows which parts of the EEG signal affect the diagnosis. This helps doctors interpret how the system reaches its conclusions.

In the second study, Privacy–preserving dementia classification from EEG via hybrid–fusion EEGNetv4 and federated learning, the researchers developed a small and resource-efficient AI model – under one megabyte in size – that also safeguards patient privacy. With the help of federated learning, multiple healthcare providers can collaborate to train the AI system without sharing patient data. Despite the privacy protection, the model achieves over 97 per cent accuracy.

“Traditional machine learning models often lack transparency and are challenged by privacy concerns. Our study aims to address both issues,” says Muhammad Hanif, associate senior lecturer of informatics at Örebro University.

AI detects patterns in the brain’s electrical signals

The researchers have succeeded in combining different methods of interpreting the brain’s electrical signals. By dividing EEG signals into various frequency bands – alpha, beta and gamma waves – the AI can identify patterns linked to dementia. The algorithms can detect long-term changes in the signals and recognise subtle differences between diagnoses. In addition, the explainable AI technology ensures the system is no longer a “black box” – it clearly shows the basis for its decisions.

In their studies, the researchers demonstrate how AI can become a rapid, low-cost and privacy-safe tool for early diagnosis of dementia. EEG is already a simple and inexpensive method that can be used in primary care. Combined with AI models that can run on portable devices, this opens up the potential for wider use in healthcare – from specialist clinics to future home testing.

The AI test could be used at home in the future

“Early diagnosis is essential for implementing proactive measures that slow disease progression and improve quality of life. If solutions like this are fully implemented, it could ease the burden for everyone involved – patients, care staff, relatives and healthcare professionals,” says Muhammad Hanif.

The studies were conducted in collaboration between researchers at Örebro University and several international institutions, including universities in the UK, Australia, Pakistan and Saudi Arabia.

“We plan to continue the research by expanding to larger and more diverse datasets, exploring more EEG features, and including other types of dementia such as vascular dementia and Lewy body dementia. At the same time, we will use explainable AI and ensure strict protection of patient data,” explains Muhammad Hanif.

An explainable and efficient deep learning framework for EEG-based diagnosis of Alzheimer's disease and frontotemporal dementia.
Khan W, Khan MS, Qasem SN, Ghaban W, Saeed F, Hanif M and Ahmad J (2025)
Front. Med. 12:1590201. doi: 10.3389/fmed.2025.1590201
Published: 15 July 2025
Archivos adjuntos
  • Muhammad Hanif, researcher in Informatics at Örebro University, Sweden. Photo: Jerry Gray
27/11/2025 Örebro Universitet
Regions: Europe, Sweden, United Kingdom, Oceania, Australia, Asia, Pakistan, Middle East, Saudi Arabia
Keywords: Applied science, Artificial Intelligence, Health, Medical, Well being

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonios

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Trabajamos en estrecha colaboración con...


  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2025 by DNN Corp Terms Of Use Privacy Statement